Predictors of death during 10 years after coronary artery bypass grafting with particular emphasis on age

Coronary Artery Disease

Volumn 15, Issue 3, 2004, Pages 163-170

  Herlitz, Johan ^a   Brandrup Wognsen, Gunnar ^a   Caidahl, Kenneth ^a   Haglid, Maria ^a   Karlson, Björn W ^a   Hartford, Marianne ^a   Karlsson, Thomas ^a   Sjöland, Helén ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age; Coronary artery bypass grafting; Ischemic heart disease; Long term; Prognosis

Indexed keywords

ANTIDIABETIC AGENT; DIGITALIS;

ADULT; AGED; ANAMNESIS; ANGINA PECTORIS; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; EVALUATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMITTENT CLAUDICATION; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SWEDEN; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VENTILATOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; SWEDEN; TIME FACTORS;

EID: 2342481134     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200405000-00005     Document Type: Review

References (35)

1. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; II:1173-1180.
2. Coronary Artery Surgery Study (CASS) principal investigators and their associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Circulation 1983; 68:951-960.
3. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialist Collaboration. Lancet 1994; 344:563-570.
4. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
5. Bray GA. Obesity and the heart. Mod Concepts Cardiovasc Dis 1987; 56:67-71.
6. Herlitz J, Brandrup-Wognsen G, Haglid M, Karlson BW, Hartford M, Karlsson T. Predictors of death during 5 years after coronary artery bypass grafting. Int J Cardiol 1998; 64:15-23.
7. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO, for the Coronary Artery Surgery Study (CASS) investigators. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. J Am Coll Cardiol 1992; 20:287-294.
8. Herlitz J, Haglid M, Albertsson P, Westberg S, Karlson BW, Hartford M, et al. Short- and long-term prognosis after coronary artery bypass grafting in relation to smoking habits. Cardiology 1997; 88:492-497.
9. Eliasson M, Asplund K, Everin PE, Lundblad D. Relationship of cigarette smoking and snugg dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 1995; 113:41-53.
10. Mezzetti A, Lapenn D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 1995; 112:91-99.
11. Calermajer D, Sorensen K, Bull C, Robinson J, Deanfield J. Endothelium- dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24:1468-1474.
12. Kiowski W, Under L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-I in clinically healthy smokers. Circulation 1994; 90:27-34.
13. Higman D, Powel J, Greenhalgh R, Coady A, Moss J. Is thickening of the basal lamina in the saphenous vein a hallmark of smoking? Br Heart J 1994; 71:45-50.
14. Epstein SE, Palmeri ST, Patterson RE. Evaluation of patients after myocardial infarction: indications for cardiac catheterization and surgical intervention. N Engl J Med 1982; 307:1487-1492.
15. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990; 322:743-753.
16. Brandrup-Wognsen G, Haglid M, Karlsson T, Berggren H, Herlitz J. Preoperative risk indicators of death at an early and late stage after coronary artery bypass grafting. Thorac Cardiovasc Surg 1995; 43:77-82.
17. Hammermeister KE, Burchfiel C, Johnson R, Grover FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990; 82:380-389.
18. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA 1992; 267:2344-2348.
19. Lubin MF. Is age a risk factor for surgery? Med Clin N Am 1993; 77:327-333.
20. Horvath KA, DiSesa VJ, Peigh PS, Couper GS, Collins JJ, Cohn LH. Favourable results of coronary artery bypass grafting in patients older than 76 years. J Thorac Cardiovasc Surg 1990; 99:92-96.
21. Brandrup-Wognsen G, Berggren H, Hartford M, Karlson BW, Karlsson T, Herlitz J. Mortality and morbidity during a period of 2 years after coronary artery bypass grafting in relation to age. Cardiol Elderly 1995; 3:289-295.
22. Fyller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989; 97:821-82.
23. Bigger JT, Fleiss JL, Rolnitzky LM, Merab JP, Ferrick KJ. Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol 1985; 55:623-630.
24. Herlitz J, Bȧng A, Sjölin M, Karlson BW. Five-year mortality after acute myocardial infarction in relation to previous history, level of initial care, complications in hospital and medication at discharge. Cardiovasc Drugs Ther 1996; 10:485-490.
25. Madsen EB, Gilpin E, Henning H, Ahnve S, LeWinter M, Mazur J, et al. Prognostic importance of digitalis after acute myocardial infarction. J Am Coll Cardiol 1984; 3:681-689.
26. van Veldhuisen DJ, de Graeff PA, Remme WJ, Lie KI. Value of digoxin in heart failure and sinus rhythm: new features of an old drug? J Am Coll Cardiol 1996; 28:813-819.
27. Malmberg K, Rydén L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9:259-264.
28. Herlitz J, Karlson BW, Lindqvist J, Sjölin M. Rate and mode of death during five years of follow-up among patients with acute chest pain with and without a history of diabetes mellitus. Diabet Mad 1998; 15:308-314.
29. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21:920-925.
30. Herlitz J, Brandrup Wognsen G, Emanuelsson H, Haglid M, Karlson BW, Karisson T, et al. Mortality and morbidity in diabetic and non diabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996; 19:698-703.
31. Morris JJ, Smith CR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, et al. Influence of diabetes and mammary artery grafting on survival after coronary byass. Circulation 1991; 84:275-284.
32. Smith LR, Harrell FE, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991; 84: 245-253.
33. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
34. The Heart Outcomes Prevention Evaluation Study investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-153.
35. O'Connor GT, Plume SK, Olmstead EM, Morton JR, Maloney CT, Nugent WC, et al. A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. JAMA 1996; 275:841-846.